Study Setup Shouldn’t Take Weeks. It’s a Design Choice.

Picture of Anna-Liisa Parts

Anna-Liisa Parts

Co-founder, COO

Friday evening. Signed contract in the inbox.

By Monday lunch, the study was live. Full TMF structure. Sites connected. Teams in. Ready for review.

Four hours.

I keep hearing that study setup takes weeks. And here’s the uncomfortable truth nobody wants to say out loud: those weeks are not a regulatory requirement. They are a product decision someone made and never questioned again.

 

The industry has normalized the wrong thing

Study start-up, the phase before a single patient is enrolled, can take anywhere from eight weeks to over six months. That’s the part where your system, your eTMF, your site access, your team permissions… all get configured. Manually. One folder at a time.

Over half of clinical sites (55%) report that setup and training on sponsor technology is extremely or very burdensome; and 67% say it’s gotten worse over the last five years. Worse. Not better. Despite a decade of “digital transformation” in clinical trials.

Meanwhile, complexity from disconnected technology drove a 39% jump in trial timelines between 2008 and 2019. And the systems sold as solutions are often part of the problem.

This is not a technology constraint. It is a design failure.

 

The dirty secret of legacy eTMF systems

Legacy platforms were built in an era of bespoke implementation. Every study was a professional services engagement. Every setup required a consultant. Every site access request went through a ticket queue.

That model made vendors money. It did not make trials faster.

When a product team designs a system where TMF structure requires manual configuration, one artifact at a time; where site onboarding means individual access requests; where setting up a study is its own sub-project; they have made a choice. A deliberate architectural choice that puts revenue generation ahead of trial velocity.

And study teams sit and wait. For weeks. To get into a system that was supposed to help them move faster.

That’s not a feature. That’s friction disguised as process.

 

What “built right” actually looks like

The DIA TMF Reference Model, the industry-standard taxonomy every eTMF claims to follow, is not complex. It is a logical, hierarchical structure of zones, sections, and artifacts. Any system that understands this structure should be able to auto-generate a compliant TMF index the moment a study is created.

Sites connected? That should be a click, not a workflow.

Team permissions? Role-based access tied to study type, not a ticket to IT.

ICH E6(R3) is here. It demands risk-proportionate oversight, contemporaneous filing, and real-time TMF health visibility. The systems that can’t set up a study in hours are the same systems that will struggle to demonstrate continuous compliance under the new standard.

The question is no longer “does your eTMF store documents?”

It’s: “does your eTMF eliminate the operational drag that delays your trial before it even begins?”

 

The hours vs. weeks gap is a competitive differentiator

In an industry where every delayed day of setup is a delayed day of enrollment and where patient recruitment is already the #1 cause of trial delays, speed-to-study-start is not a nice-to-have. It is a clinical and commercial imperative.

If your current system takes weeks to configure a study, you are not paying for compliance.

You are paying for someone else’s poor product decisions.

The clinical operations teams deserve better. The sites, already reporting that sponsor technology burdens are worsening, deserve better. And patients waiting for those trials definitely deserve better.

Setup is not a project. It should be a morning.

Want to see what a 4-hour study setup actually looks like in practice?

Book a demo with Menken Trials →

Related posts

The clinical industry treats eTMF and eISF as separate worlds, but they are simply two halves of the same study record. This post explains why that separation is a legacy of paper, not a requirement of modern compliance.
192 non-compliances were identified in a clinical study that appeared fully under control, with no audits, inspections, or visible issues. This case reveals how hidden compliance gaps quietly accumulate in complex trials and why continuous monitoring, not periodic review, is essential to achieving true inspection readiness.
See what happens when you ask “What’s missing from Zone 4?” and “Are we inspection-ready?” — and how Menka AI responds in real time.
The Trial Master File is the complete documentary record of your clinical trial. Learn what it must contain, what regulators look for, and how to keep it inspection-ready throughout your study.
How to configure dashboards, assign studies, set up visit workflows, and give your line managers the visibility they need from day one.
Menken Trials viib ellu strateegilise arendusprojekti, et tugevdada oma positsiooni Euroopa kliiniliste uuringute maastikul ja tuua uuenduslik vastavusplatvorm rohkemate meeskondadeni.

Menken Trials was built by people who’ve been there. CRAs, study managers, and clinical professionals who know the pressure of compliance, timelines, and documentation. Our tools are shaped by firsthand experience and designed to reduce admin burden so trial teams can focus on what matters most.